STAT3 and neoplasm: This is of importance, as the previous animal studies that described tumor-stroma IL-6/STAT3 communication [69] and reported the efficacy of the combined STAT3 and MEK inhibition to overcome immunotherapy resistance in PDAC [70,71] did not report the sex of the animals used.